Tony Bahinski

Tony Bahinski has a diverse work experience in the field of biomedical research and development. Tony is currently serving as the Chief Technology Officer at Vivodyne, where they lead the translation of the company's automated platform for safety and efficacy testing on lab-grown human tissues to pharmaceutical and regulatory partners. Prior to this role, Tony worked at GlaxoSmithKline as the Global Head of Safety Pharmacology from 2016 to 2022. Tony was responsible for overseeing safety pharmacology activities during this time.

Before joining GlaxoSmithKline, Tony worked at the Wyss Institute for Biologically Inspired Engineering at Harvard University as a Lead Senior Staff Scientist. Tony'sresearch focused on the development of organ-on-a-chip technology for preclinical safety and efficacy evaluation of various substances. Tony also contributed to the development of replacements for animal testing. Tony worked at the Wyss Institute from 2010 to 2016.

Tony also has experience working at Pfizer, where they held various positions. Tony was a Research Fellow and the St. Louis site lead for Pfizer Global Safety Pharmacology. Tony was responsible for overseeing safety pharmacology activities at the St. Louis site from 2008 to 2010. Prior to this, they held the position of Associate Research Fellow, contributing to research and development efforts. Tony was also a member of the Safety Pharmacology Society from 2007 to 2010.

Tony began their career as a Senior Scientist at P&G Pharmaceuticals and completed their post-doctoral research at the University of Cincinnati.

Overall, Tony Bahinski's work experience showcases their expertise in safety pharmacology, development of preclinical evaluation methods, and leadership in the field of biomedical research and development.

Tony Bahinski began their education in 1976 at Drexel University, where they obtained a Bachelor of Science (BS) degree in Biology in 1981. Tony then pursued further studies at Temple University - Lewis Katz School of Medicine from 1981 to 1986, earning a Doctor of Philosophy (PhD) degree in Physiology. Lastly, Tony attended Xavier University - Williams College of Business to pursue a Master of Business Administration (MBA) degree, although the specific dates of their enrollment and completion are not provided.